Aditxt, Inc. financial data

Symbol
ADTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
737 N. Fifth Street, Suite 200, Richmond, VA
State of incorporation
DE
Fiscal year end
December 31
Former names
ADiTx Therapeutics, Inc. (to 7/6/2021), Aditx Therapeutics, Inc. (to 7/6/2021)
Latest financial report
10-Q - Q3 2024 - Nov 18, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.7 % -65.8%
Quick Ratio 2.3 %
Debt-to-equity 253 %
Return On Equity -502 % -112%
Return On Assets -140 % +60%
Operating Margin -14.2K % -305%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.2M shares +3121%
Common Stock, Shares, Outstanding 531K shares +44.4%
Entity Public Float 3.01M USD -62%
Common Stock, Value, Issued 532 USD +44.6%
Weighted Average Number of Shares Outstanding, Basic 116K shares +2177%
Weighted Average Number of Shares Outstanding, Diluted 116K shares +2177%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 212K USD -71.7%
Cost of Revenue 842K USD +337%
Research and Development Expense 9.29M USD +58.8%
Selling and Marketing Expense 140K USD -32.1%
General and Administrative Expense 14.9M USD -21%
Operating Income (Loss) -30.2M USD -14.6%
Nonoperating Income (Expense) -10.3M USD -213%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -40.5M USD -36.7%
Net Income (Loss) Attributable to Parent -45.9M USD -54.3%
Earnings Per Share, Basic 1.81K USD/shares +94.3%
Earnings Per Share, Diluted 1.81K USD/shares +94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 329K USD -80.1%
Accounts Receivable, after Allowance for Credit Loss, Current 352K USD -3.03%
Inventory, Net 89K USD -89.6%
Assets, Current 2.09M USD -39.1%
Property, Plant and Equipment, Net 1.72M USD -14.4%
Operating Lease, Right-of-Use Asset 1.39M USD -43.4%
Intangible Assets, Net (Excluding Goodwill) 6.94K USD -74%
Other Assets, Noncurrent 348K USD -17.7%
Assets 29.8M USD +263%
Liabilities, Current 24.4M USD +117%
Operating Lease, Liability, Noncurrent 592K USD -50.8%
Liabilities 25.4M USD +104%
Retained Earnings (Accumulated Deficit) -163M USD -39.7%
Stockholders' Equity Attributable to Parent 4.71M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.45M USD
Liabilities and Equity 29.8M USD +263%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.96M USD -50.8%
Net Cash Provided by (Used in) Financing Activities 5.95M USD +299%
Net Cash Provided by (Used in) Investing Activities -5.05K USD +98.6%
Common Stock, Shares Authorized 1B shares +900%
Common Stock, Shares, Issued 531K shares +44.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.47M USD +57.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 329K USD -80.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 623K USD +222%
Deferred Tax Assets, Valuation Allowance 26.4M USD +30.7%
Deferred Tax Assets, Gross 27M USD +28.1%
Operating Lease, Liability 1.27M USD -44.4%
Depreciation 554K USD +20%
Payments to Acquire Property, Plant, and Equipment 5.05K USD
Lessee, Operating Lease, Liability, to be Paid 1.31M USD -46%
Property, Plant and Equipment, Gross 3.42M USD +8.46%
Operating Lease, Liability, Current 678K USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 424K USD -57.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 711K USD +148%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38K USD -72.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 424K USD -40.3%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +37.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 424K USD
Additional Paid in Capital 168M USD +49%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 29.8K USD -72.1%
Deferred Tax Assets, Net of Valuation Allowance 630K USD -29.8%
Operating Leases, Future Minimum Payments Due 1.42M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%